Mammalian cells secreting gdnf and their therapeutic use
Номер патента: EP4081262A1
Опубликовано: 02-11-2022
Автор(ы): Lars U. Wahlberg
Принадлежит: Gloriana Therapeutics Inc
Опубликовано: 02-11-2022
Автор(ы): Lars U. Wahlberg
Принадлежит: Gloriana Therapeutics Inc
Реферат: The present invention concerns methods and compositions for gene therapy, in particular in vivo gene therapy for delivery of bioactive glial derived neurotrophic factor (GDNF) for the treatment of Parkinson's Disease. The invention also concerns mammalian cells capable of producing GDNF in increased amounts as well as the use of these cells for recombinant production of bioactive GDNF and for therapeutic use.
Mammalian cells secreting gdnf and their therapeutic use
Номер патента: WO2021138350A1. Автор: Lars U. Wahlberg. Владелец: Gloriana Therapeutics. Дата публикации: 2021-07-08.